Morningstar

DexCom Inc DXCM

Morningstar Rating
Unlock
Stock XNAS Rating as of
$85.36 −0.87 (1.01%)
View Full Chart
As of Delayed Price Post-Trading: $85.35 −0.01

Company Report

View Archive

DexCom Faces Potential Headwinds in 2026, but Expanding Reimbursement Offers Long-Term Prospects

Debbie S. Wang

DexCom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, DexCom has captured an impressive slice of the CGM market, despite a recent wave of innovation in diabetes devices that has intensified competitive pressure. DexCom has done a credible job of adapting and fending off competition from Abbott and Medtronic.

Read Analysis

Price vs Fair Value

View History
DXCM is trading within a range we consider fairly valued.
Price
$86.23
Fair Value
>Z
Uncertainty
LOCK|gN
1-Star Price
LOCK|V.h?
5-Star Price
LOCK|.D
Economic Moat
LOCK|N#ckJ
Capital Allocation
LOCK|@VdnHWy

Bulls Say, Bears Say

Bulls

DexCom's G7 product is significantly less expensive and offers a thinner profile and faster warm-up time than the G6.

Bears

Considering DexCom's sensors are already the most accurate, there's less opportunity for significant improvements on that dimension, compared with key competitors.

Show More

News

View All

Trading Information

Previous Close Price
$86.23
Day Range
$84.80–86.67
52-Week Range
$54.11–92.59
Bid/Ask
$85.00 / $86.36
Shares Outstanding
377.36M
Market Cap
$32.21B
Volume/Avg
2M / 5M

Key Statistics

Price/Earnings (Normalized)
33.80
Price/Sales
6.90
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
3.31%

Company Profile

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Growth
Total Number of Employees
11,100
Website
https://www.dexcom.com

Competitors

Valuation

View More
Metric
DXCM
MDT
PODD
Price/Earnings (Normalized)
 33.8015.2722.28
Price/Book Value
 12.412.206.38
Price/Sales
 6.902.963.06
Price/Cash Flow
 22.1012.4015.15
Price/Earnings
DXCM
MDT
PODD

Financial Strength

Metric
DXCM
MDT
PODD
Quick Ratio
 1.371.291.51
Current Ratio
 1.732.072.48
Interest Coverage
 80.1610.129.04
Quick Ratio
DXCM
MDT
PODD

Profitability

Metric
DXCM
MDT
PODD
Return on Assets (Normalized)
 14.49%8.31%13.00%
Return on Equity (Normalized)
 36.44%15.59%29.07%
Return on Invested Capital (Normalized)
 20.31%10.57%17.78%
Return on Assets
DXCM
MDT
PODD

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|TW#>tQLLOCK|Hvw<?$167B
 Medtronic PLC
MDT
LOCK|K^wZ^%LOCK|D<n<$111B
 Stryker Corp
SYK
LOCK|@!wmb>vHLOCK|@d$105B
 Boston Scientific Corp
BSX
LOCK|&t&y$^LOCK|@@?@@$63B
 Edwards Lifesciences Corp
EW
LOCK|@#h><d?LOCK|?th^$49B
 GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|z@#!lfLOCK|?@f$29B
 Koninklijke Philips NV ADR
PHG
LOCK|N&LOCK|!G$23B
 Steris PLC
STE
LOCK|kl>f%qdLOCK|X<^Rn$20B
 Zimmer Biomet Holdings Inc
ZBH
LOCK|wv%qCs%?LOCK|#@$17B

Sponsor Center